Scinovex
article Open Access

Clinical study of outcome in the management of BPH with obstructive nephropathy

International Journal of Surgery Science · 2021 · Vol. 5(1) · pp. 263–266

Abstract

Background: Benign Prostate Hyperplasia (BPH) is a common disease in adult men and its incidence is age related. While the underlying mechanism for developing renal failure associated with benign prostatic hyperplasia is likely multifactorial and co-morbid factors in elderly men may contribute to renal impairment. We aimed that to determine the association of benign prostatic obstruction with nephropathy. Materials and Methods: A Prospective study was conducted at JSS Hospital, Karnataka, between June 2010 to June 2012. A total 30 patients were included after informed consent. Blood samples were collected from all the subjects. IPSS, QoL Score, Residual urine, Serum Creatinine, Prostatic volume and Hemodialysis was done. Results: The present study evaluates the IPSS and QoL Score, Residual urine, Serum Creatinine, Prostatic volume and Hemodialysis in patients with BPH showed a positive relation with nephropathy. Along with that we analyzed all the parameters pre and post OP IPSS (24.75 ± 1.88, 14.27±3.66), QoL Score (4.65 ±0.66, 1.93±0.75), Residual urine 442.48±225.65, 44.89± 47.50), Serum Creatinine (3.04± 2.13 1.28±0.49), and Hemodialysis (3(10%), 2 (6%). Conclusion: This study concludes Strong inter-relation between the two such that BPH can cause renal failure while renal failure can influence the management of BPH and its outcome.

Prostate Cancer Diagnosis and TreatmentUrinary Bladder and Prostate ResearchHormonal and reproductive studiesMedicineUrologyCreatinineHemodialysisHyperplasiaInternational Prostate Symptom ScoreUrineProspective cohort studyIncidence (geometry)Internal medicine
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
2%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Clinical study of outcome in the management of BPH with obstructive nephropathy · Scinovex